Nivolumab plus doxorubicin, vinblastine, and dacarbazine (N-AVD) for newly diagnosed advanced-stage classical Hodgkin lymphoma (cHL): results from Cohort D of the phase 2 CheckMate 205 study

被引：0

作者：

Engert, A. ^{[1
]}

Domingo Domenech, E. ^{[2
]}

Rueda, A. ^{[3
]}

Armand, P. ^{[4
]}

Trneny, M. ^{[5
]}

Feldman, T. ^{[6
]}

Ansell, S. ^{[7
]}

Provencio, M. ^{[8
]}

Jaeger, U. ^{[9
]}

Cohen, J. B. ^{[10
]}

Savage, K. J. ^{[11
]}

Willenbacher, W. ^{[12
,13
]}

Sacchi, M. ^{[14
]}

Sumbul, A. ^{[14
]}

Ramchandren, R. ^{[15
]}

机构：

[1] Univ Hosp Cologne, Cologne, Germany

[2] ICO, Barcelona, Spain

[3] Costa del Sol Hosp, Marbella, Spain

[4] Dana Farber Canc Inst, Boston, MA 02115 USA

[5] Charles Univ Prague, Gen Univ Hosp, Prague, Czech Republic

[6] Hackensack Univ, Med Ctr, Hackensack, NJ USA

[7] Mayo Clin, Rochester, MN USA

[8] Hosp Univ Puerta de Hierro, Madrid, Spain

[9] Med Univ Vienna, Vienna, Austria

[10] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[11] Canc Agcy Ctr Lymphoid Canc, Vancouver, BC, Canada

[12] Univ Innsbruck Hosp, Innsbruck, Austria

[13] OncoTyrol Ctr Personalized Care Med, Innsbruck, Austria

[14] Bristol Myers Squibb, Princeton, NJ USA

[15] Barbara Ann Karmanos Canc Inst, Detroit, MI USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2018年 / 41卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

V853

引用

页码：273 / 273

页数：1

共 50 条

[21] Sequential Brentuximab Vedotin (Bv) before and after Adriamycin, Vinblastine, and Dacarbazine (Bv-AVD) for Older Patients with Untreated Classical Hodgkin Lymphoma (cHL): Final Results from a Multicenter Phase II Study [J].

Evens, Andrew M. ;

Advani, Ranjana H. ;

Fanale, Michelle A. ;

Smith, Sonali M. ;

Helenowski, Irene ;

Jovanovic, Borko ;

Bociek, R. Gregory ;

Klein, Andreas ;

Winter, Jane N. ;

Gordon, Leo I. ;

Hamlin, Paul A. .

BLOOD, 2017, 130

[22] Results from an Open-Label, Phase 1/2 Study of Frontline Brentuximab Vedotin Plus Adriamycin, Vinblastine, and Dacarbazine in Pediatric Patients with Advanced Stage Hodgkin Lymphoma [J].

Franklin, A. ;

Luisi, F. ;

Pianovski, M. ;

Salvino, M. ;

Fagioli, F. ;

Epelman, S. ;

De Abreu Lima, L. B. ;

Norris, R. ;

Filho, V. O. ;

Zecca, M. ;

Favre, C. ;

Kobayashi, R. ;

Koga, Y. ;

Sidi, Y. ;

Campana, F. ;

Leonard, E. J. ;

Locatelli, F. .

PEDIATRIC BLOOD & CANCER, 2021, 68 :S78-S79

[23] Phase II study of ABV (doxorubicin with increased dose, bleomycin and vinblastine) therapy in newly diagnosed advanced-stage Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG9705) [J].

Ogura, Michinori ;

Itoh, Kuniaki ;

Ishizawa, Kenichi ;

Kobayashi, Yukio ;

Tobinai, Kensei ;

Kinoshita, Tomohiro ;

Hirano, Masami ;

Ueda, Ryuzo ;

Shibata, Taro ;

Nakamura, Shigeo ;

Tsukasaki, Kunihiro ;

Hotta, Tomomitsu ;

Shimoyama, Masanori ;

Morishima, Yasuo .

LEUKEMIA & LYMPHOMA, 2013, 54 (01) :46-52

[24] Prognostic Factors for Advanced-Stage Human Immunodeficiency Virus-Associated Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Plus Combined Antiretroviral Therapy A Multi-Institutional Retrospective Study [J].

Castillo, Jorge J. ;

Bower, Mark ;

Bruehlmann, Jeremy ;

Novak, Urban ;

Furrer, Hansjakob ;

Tanaka, Paula Y. ;

Besson, Caroline ;

Montoto, Silvia ;

Cwynarski, Kate ;

Abramson, Jeremy S. ;

Dalia, Samir ;

Bibas, Michele ;

Connors, Joseph M. ;

Furman, Michael ;

Minh-Ly Nguyen ;

Cooley, Timothy P. ;

Beltran, Brady E. ;

Collins, Jaime A. ;

Vose, Julie M. ;

Xicoy, Blanca ;

Ribera, Josep-Maria .

CANCER, 2015, 121 (03) :423-431

[25] Phase-II study of rituximab plus ABVD for the treatment of newly diagnosed patients with advanced stage classical Hodgkin lymphoma (HL) [J].

Younes, A. ;

Fayad, L. ;

Goy, A. ;

McLaughlin, P. ;

Pro, B. ;

Romaguera, J. ;

Hagemeister, F. ;

Rodriguez, M. A. ;

Samaniego, E. ;

Kwak, L. ;

Neelapu, S. ;

Medeiros, L. J. ;

Wedgwood, A. ;

Fanale, M. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 :33-33

[26] TARGETED BEACOPP VARIANTS IN PATIENTS WITH NEWLY DIAGNOSED ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA: INTERIM RESULTS OF A RANDOMIZED PHASE II STUDY [J].

Borchmann, P. ;

Eichenauer, D. ;

Pluetschow, A. ;

Kreissl, S. ;

Fuchs, M. ;

Soekler, M. ;

Engel, N. ;

Mathas, S. ;

Behringer, K. ;

Kobe, C. ;

Dietlein, M. ;

Diehl, V. ;

Engert, A. .

HAEMATOLOGICA, 2014, 99 :497-498

[27] Prednisone, Vinblastine, Doxorubicin and Bendamustine (PVAB) Regimen in First Line Therapy for Older Patients with Advanced-Stage Classical Hodgkin Lymphoma: Results of a Prospective Multicenter Phase II Trial of the Lymphoma Study Association (LYSA) [J].

Ghesquieres, Herve ;

Casasnovas, Olivier ;

Nicolas-Virelizier, Emmanuelle ;

Laurent, Damaj Gandhi ;

Delwail, Vincent ;

Touati, Mohamed ;

Le Du, Katell ;

Morschhauser, Franck ;

Bonnet, Christophe ;

Waultier-Rascalou, Agathe ;

Orsini-Piocelle, Frederique ;

Andre, Marc ;

Ben Boutieb, Myriam ;

Morand, Fabienne ;

Damotte, Diane ;

Traverse-Glehen, Alexandra ;

Quittet, Philippe ;

Brice, Pauline .

BLOOD, 2019, 134

[28] Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN plus AD) for Advanced Stage Classic Hodgkin Lymphoma: Preliminary Safety Results from the Single-Arm Phase 2 Study (SGN35-027 Part B) [J].

Lee, Hun Ju ;

Flinn, Ian W. ;

Melear, Jason ;

Ramchandren, Rod ;

Friedman, Judah ;

Burke, John M. ;

Linhares, Yuliya ;

Peterson, Matthew R. ;

Raval, Mihir ;

Chintapatla, Rangaswamy ;

Feldman, Tatyana A. ;

Yimer, Habte ;

MiguelIslas-Ohlmayer ;

Dean, Asad ;

Rana, Vishal ;

Gandhi, Mitul D. ;

Renshaw, John ;

Gillespie-Twardy, Amanda L. ;

Ho, Linda ;

Fanale, Michelle A. ;

Guo, Wenchuan ;

Yasenchak, Christopher A. .

BLOOD, 2021, 138

[29] Nivolumab Treatment Beyond Investigator-Assessed Progression: Outcomes in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma from the Phase 2 Checkmate 205 Study [J].

Cohen, Jonathon B. ;

Engert, Andreas ;

Ansell, Stephen M. ;

Younes, Anas ;

Trneny, Marek ;

Savage, Kerry J. ;

Ramchandren, Radhakrishnan ;

Collins, Graham ;

Fanale, Michelle A. ;

Armand, Philippe ;

Zinzani, Pier Luigi ;

De Boer, Jan Paul ;

Shipp, Margaret A. ;

Santoro, Armando ;

Timmerman, John M. ;

Sacchi, Mariana ;

Sy, Oumar ;

Kuruvilla, John .

BLOOD, 2017, 130

[30] Nivolumab Treatment Beyond Investigator-Assessed Progression: Outcomes in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma From the Phase 2 CheckMate 205 Study [J].

Cohen, J. B. ;

Engert, A. ;

Ansell, S. M. ;

Younes, A. ;

Trneny, M. ;

Savage, K. J. ;

Ramchandren, R. ;

Collins, G. P. ;

Fanale, M. A. ;

Armand, P. ;

Zinzani, P. L. ;

de Boer, J. P. ;

Shipp, M. A. ;

Santoro, A. ;

Timmerman, J. M. ;

Sacchi, M. ;

Sy, O. ;

Kuruvilla, J. .

BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 :87-88

← 1 2 3 4 5 →